Resmed divests MatrixCare business

SAN DIEGO – Resmed has entered a definitive agreement to sell its MatrixCare business to Frazier Healthcare Partners, a private equity firm focused on health care. Resmed bought MatrixCare, which provides software solutions to more than 15,000 providers and supports skilled nursing, senior living and long-term care, life planning communities and home health and hospice care, for $750 million in 2018.

Resmed says the sale reflects its 2030 strategy to focus on high-growth, scalable opportunities in sleep health, breathing health and connected home-based health care. The company also says it strengthens its ability to reallocate capital and resources toward innovation, operational scale and long-term value creation across its connected, home-based care ecosystem.

“Today’s announcement is about our disciplined approach to portfolio management and our commitment to driving long-term growth,” said Mick Farrell, chairman and CEO of Resmed. “By focusing on areas where we see the greatest opportunity for sleep health innovation and impact, we are strengthening our ability to deliver life-changing health technologies, improve patient outcomes and create value for our stakeholders. We are confident MatrixCare and its affiliated businesses will continue to support team members and drive growth under new ownership with a dedicated focus on the long-term care market.”

Resmed still owns software vendors Brightree, which it bought in 2016, and MEDIFOX DAN, which it bought in 2022.

The sale includes MatrixCare and related software offerings historically sold under the MatrixCare brand, including Healthcare First, Citus and home health and hospice solutions.

Resmed expects the sale to close during the first quarter of its fiscal year 2027, subject to required regulatory approvals and customary closing conditions. Until closing, MatrixCare will continue to operate as part of Resmed, with no changes to customer service or support.

• Related: Resmed best on technology play.